OICR Invests $49M in Genomics, Translational Research Programs | GenomeWeb

NEW YORK (GenomeWeb News) – The Ontario Institute for Cancer Research has pumped C$52 million ($49.3 million) into several genomic and translational research programs aimed at developing new diagnostics and treatments for cancer, OICR said today.

The new investment will concentrate on supporting programs and research areas that the institute deems to be of high interest, including ones centering on cancer genomics and stem cells, drug discovery, informatics, and pathology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.